Sei Investments Co. Decreases Holdings in Transcat, Inc. $TRNS

Sei Investments Co. reduced its holdings in shares of Transcat, Inc. (NASDAQ:TRNS) by 46.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 18,397 shares of the scientific and technical instruments company’s stock after selling 16,136 shares during the quarter. Sei Investments Co. owned approximately 0.20% of Transcat worth $1,351,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Transcat by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 530,771 shares of the scientific and technical instruments company’s stock worth $38,852,000 after acquiring an additional 2,041 shares in the last quarter. Royce & Associates LP boosted its holdings in Transcat by 15.3% in the fourth quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock valued at $22,156,000 after purchasing an additional 51,774 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Transcat by 3.7% in the first quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company’s stock valued at $19,244,000 after purchasing an additional 9,266 shares in the last quarter. Wellington Management Group LLP increased its stake in Transcat by 677.7% in the fourth quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company’s stock valued at $14,100,000 after purchasing an additional 216,579 shares during the last quarter. Finally, Bamco Inc. NY increased its stake in Transcat by 6.2% in the fourth quarter. Bamco Inc. NY now owns 203,477 shares of the scientific and technical instruments company’s stock valued at $11,543,000 after purchasing an additional 11,911 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Insider Buying and Selling

In other Transcat news, Director Craig D. Cairns purchased 1,050 shares of Transcat stock in a transaction that occurred on Thursday, August 6th. The stock was purchased at an average price of $93.97 per share, for a total transaction of $98,668.50. Following the transaction, the director directly owned 1,480 shares in the company, valued at $139,075.60. This trade represents a 244.19% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.80% of the stock is currently owned by company insiders.

Transcat Trading Up 5.0%

TRNS opened at $95.39 on Wednesday. The firm has a market cap of $892.85 million, a price-to-earnings ratio of 257.81 and a beta of 0.68. Transcat, Inc. has a 52 week low of $50.23 and a 52 week high of $98.36. The business’s 50 day moving average is $89.75 and its two-hundred day moving average is $80.14. The company has a quick ratio of 2.11, a current ratio of 2.49 and a debt-to-equity ratio of 0.36.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $92.95 million during the quarter, compared to analysts’ expectations of $86.55 million. Transcat had a return on equity of 5.56% and a net margin of 0.99%. On average, research analysts predict that Transcat, Inc. will post 1.74 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on TRNS shares. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research report on Friday, May 15th. Northland Securities downgraded shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 target price on the stock. in a research report on Wednesday, August 5th. Weiss Ratings raised shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, May 28th. Finally, Wall Street Zen upgraded shares of Transcat from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $105.50.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.